Seeking Alpha

Javelin Pharmaceuticals (JAV -28.6%) shares plummet after Hospira (HSP +0.5%) announces an...

Javelin Pharmaceuticals (JAV -28.6%) shares plummet after Hospira (HSP +0.5%) announces an extension of its tender offer to June 2. Javelin disagrees with Hospira's position that the conditions to the tender offer have not been fully satisfied. (PR)
Comments (1)
  • Tony Petroski
    , contributor
    Comments (6373) | Send Message
     
    For you marketing students: "Javelin Pharmaceuticals?" Was "Poke in the Arm Pharmaceuticals" taken?

     

    And "Hospira?" "Vampira?"

     

    Back to basics would take us to "Healthful Pharmaceuticals" and "Sound Care Hospital Supply."
    19 May 2010, 09:57 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|